Douglas N. Ladd

Part of Humana, Inc., Choicecare Corp. is a health maintenance organization (HMO). Choicecare was acquired by Humana, Inc. on October 17, 1997 for $250 million.

EndoChoice, Inc. operates as a medtech company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Its imaging systems include fuse endoscopy system, fuse accesories, carts, cart options, monitors, monitor cart mounts, monito wall mounts, scope services, and suction pumps and supplies. Its devices include band ligators, biopsy forceps, bipolar probes, bite blocks, cytology brushes, electrosurgical supplies, metal stents, needles, retrieval devices, and snares. The company was founded by Mark G. Gilreath and William Parks in 2007 and is headquartered in Alpharetta, GA.

EndoChoice Holdings, Inc. engages in the development, design and manufacture of medical devices. It offers span single-use devices and infection control products, pathology and imaging systems. The company was founded by Mark G. Gilreath and William Parks in 2008 and is headquartered in Alpharetta, GA.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.